Eurofins | GenomeWeb

Eurofins

The lab was opened earlier this year as the company's central genomics lab in North America, offering various genomic services such as DNA sequencing.

The company is hoping to find a niche among customers who want the quality of high-throughput oligonucleotide synthesis but smaller order volumes.

Living DNA can break down the origins of a customer’s ancestry into 21 distinct regions within Britain alone, as well as across 80 different worldwide populations.

The company's subsidiary Viracor-IBT can now run the real time, reverse transcriptase-PCR assay for patients meeting clinical or epidemiological criteria for Zika.

The combined company, which will retain the Eurofins BioDiagnostics name, will offer a range of analytical testing services to the ag-bio market.

Agilent will offer its SureVector cloning kits through Eurofins and will supply components for cloning services performed by Eurofins.

The facility will be the firm's central genomics lab in North America, handling custom DNA and RNA production, synthetic gene synthesis, and genomic services.

The new joint venture will be called EGL Genetic Diagnostics.

The Belgium-based testing firm believes acquiring the university laboratory will strengthen its position in specialty clinical diagnostic testing.

Pages

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.